Related Experiment Video
Updated: Jul 15, 2026

07:11
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
[Positive ibopamine provocative test in normal-tension glaucoma suspects].
C Kniestedt1, T Romppainen, B P Gloor
1Augenklinik, Kantonspital Winterthur, Winterthur, Schweiz. christoph.kniestedt@usz.ch
Summary
Ibopamine eye drops can identify early glaucoma by causing a significant intraocular pressure increase in susceptible eyes. This test helps distinguish normal outflow from resistance, aiding in early detection of ocular hydrodynamic disorders.
Area of Science:
- Ophthalmology
- Ocular Physiology
Background:
- Ibopamine, an alpha-adrenergic agent, elevates intraocular pressure (IOP) in eyes with increased outflow resistance.
- It is a potential diagnostic tool for early ocular hydrodynamic disorders.
Purpose of the Study:
- To evaluate the efficacy of ibopamine 2% eye drops in detecting early glaucoma in normal-tension glaucoma suspects.
- To differentiate eyes with normal trabecular outflow capacity from those with increased resistance.
Main Methods:
- 64 normal-tension glaucoma suspect eyes were tested with ibopamine 2% eye drops.
- Intraocular pressure was monitored using applanation and contour tonometry before and after instillation.
- A positive test was defined as an IOP increase greater than 2.0 mmHg.
Main Results:
- 50% of eyes showed a positive pressure response to ibopamine.
- The positive test group exhibited a significant IOP increase (18.04 to 22.06 mmHg) and increased ocular pulse amplitude.
- No significant difference in central corneal thickness was observed between positive and negative test groups.
Conclusions:
- Ibopamine 2% eye drops effectively identify eyes with increased trabecular meshwork resistance.
- The test aids in differentiating eyes prone to pressure peaks and glaucoma development.
- Ibopamine shows promise for early detection of glaucoma in normal-tension glaucoma suspects.
Related Concept Videos
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

